Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) FCF Margin (2017 - 2025)

Historic FCF Margin for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to 15.54%.

  • Inspire Medical Systems' FCF Margin fell 103900.0% to 15.54% in Q4 2025 from the same period last year, while for Dec 2025 it was 8.61%, marking a year-over-year decrease of 27500.0%. This contributed to the annual value of 8.61% for FY2025, which is 27500.0% down from last year.
  • Inspire Medical Systems' FCF Margin amounted to 15.54% in Q4 2025, which was down 103900.0% from 25.87% recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' FCF Margin registered a high of 25.93% during Q4 2024, and its lowest value of 29.05% during Q1 2021.
  • Its 5-year average for FCF Margin is 0.32%, with a median of 1.96% in 2023.
  • As far as peak fluctuations go, Inspire Medical Systems' FCF Margin soared by 1881500bps in 2021, and later tumbled by -103900bps in 2025.
  • Over the past 5 years, Inspire Medical Systems' FCF Margin (Quarter) stood at 0.26% in 2021, then skyrocketed by 4516bps to 11.83% in 2022, then plummeted by -59bps to 4.8% in 2023, then surged by 441bps to 25.93% in 2024, then plummeted by -40bps to 15.54% in 2025.
  • Its FCF Margin was 15.54% in Q4 2025, compared to 25.87% in Q3 2025 and 2.91% in Q2 2025.